# HD-tDCS in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial

> **NCT06719947** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Universidade Federal do Rio Grande do Norte** · enrollment: 80 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis (ALS)

## Interventions

- **DEVICE:** Active HD-tDCS
- **DEVICE:** Simulated HD-tDCS

## Key facts

- **NCT ID:** NCT06719947
- **Lead sponsor:** Universidade Federal do Rio Grande do Norte
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2027-07
- **Final completion:** 2027-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06719947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06719947, "HD-tDCS in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT06719947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
